← Evidence map

ArticleNeuro-oncology advances

Cerebrospinal fluid D-2-hydroxyglutarate for IDH-mutant glioma monitoring.

Cecile Riviere-Cazaux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
cites it
Full record →Abstract, authors, funding and every citing paper · PMID 41853811